IBM Watson Chips in to Tackle Chronic Diseases with Big Data
FREMONT, CA: CVS Health, a pharmaceutical company, partners with IBM to enable health care practitioners to gain insights from an unprecedented mix of health information sources to help individuals with chronic diseases stay on track with their care and meet health goals.
The combined effort of both the companies will help to identify individuals with declining health and engage them withproactive, customized engagement programs to better their health. The cognitive computing capability will allow practitioners to gain insight into patient’s condition. Based on such information, patients can be encouraged to adopt safe and healthy behaviors, including adherence to prescribed medicines and healthy lifestyle regimens.
The partnership brings together IBM's Watson Health Cloud and cognitive computing capabilities and CVS Health’s medication adherence and pharmacy care. Using cognitive computing, both the companies would advance care management services. Cognitive computing involves self-learning systems that use data mining, pattern recognition and natural language processing to mimic the way the human brain works.
IBM Watson, the cognitive computing system delivered through the cloud analyzes high volumes of data, understands complex questions posed in natural language, and proposes evidence-based answers. It continuously learns, gaining in value and knowledge over time, from previous interactions. With the help of Watson, developers and partners can build apps and services that harness the power of cognitive computing to transform industries, help professionals do their jobs better, and solve important challenges.
"The capabilities of the IBM Watson Health Cloud, when coupled with CVS Health's insights into medication utilization and patient behavior, could prove transformative for the industry. Improving care for people with chronic conditions supports IBM's commitment to make big plays that advance the health and well-being of the global community," says Mike Rhodin, senior vice president, IBM Watson.